Abstract

CD4+ T cells are key players in immunology and disease pathology, including relapsing autoimmune uveitis. Equine recurrent uveitis is the only spontaneous animal model for this disease in man. Knowledge about the CD4+ cell proteome is crucial for studies on possible changes in proteome expression of CD4+ effector cells in disease. For this purpose, we generated a reference dataset of the equine CD4+ cell proteome by sorting equine CD4+ lymphocytes followed by analysis of whole cell lysate as well as membrane protein fraction using mass spectrometry.

Highlights

  • We generated a reference dataset of the equine CD4+ cell proteome by sorting equine CD4+ lymphocytes followed by analysis of whole cell lysate as well as membrane protein fraction using mass spectrometry

  • CD4+ lymphocytes play a major role in several immunological processes and diseases, including autoimmune uveitis [1]

  • Several experimental animal models exist for this disease; due to striking immunopathological and clinical similarities, equine recurrent uveitis is the only spontaneous model for relapsing autoimmune uveitis in man [2]

Read more

Summary

Introduction

CD4+ lymphocytes play a major role in several immunological processes and diseases, including autoimmune uveitis [1]. Equine recurrent uveitis is an autoimmune mediated disease affecting horses worldwide [3]. It presents with painful, remitting-relapsing inflammatory attacks of inner eye structures alternating with stages of quiescence [4]. Prior to a uveitic attack, immune cells are activated in periphery, migrate into the eye, and attack the retina [5–7]. Item 1 (Table)) as well as a separate table comprising only membrane associated proteins (Dataset Item 2 (Table)). For this purpose, CD4+ lymphocytes were isolated from total equine lymphocytes by fluorescence activated cell sorting. The two dataset items presented in this study give a detailed description of the physiological CD4+ immune cell proteome repertoire and set a reference for further comparative proteomic studies on activated cells or those altered in course of disease

Methodology
Dataset Description
Concluding Remarks
Findings
Dataset Availability
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call